CD4 and neoplasm: Moreover, many tumor cells lack MHC class II expression, so the effects of cytotoxic CD4+ T cells may be less relevant for these tumors or may rely on bystander killing on antigen-presenting cells, which could also lead to immune modulation with the tumor.